JNBA Financial Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$541K Buy
4,283
+30
+0.7% +$3.95K 0.04% 138
2026
Q1
$593K Sell
4,253
-20
-0.5% -$2.8K 0.05% 134
2025
Q4
$524K Sell
4,273
-147
-3% -$17.9K 0.05% 139
2025
Q3
$491K Hold
4,420
0.04% 136
2025
Q2
$490K Hold
4,420
0.05% 135
2025
Q1
$495K Sell
4,420
-20
-0.5% -$2.06K 0.05% 130
2024
Q4
$410K Sell
4,440
-44
-1% -$3.96K 0.04% 142
2024
Q3
$376K Sell
4,484
-100
-2% -$7.63K 0.04% 144
2024
Q2
$315K Hold
4,584
0.03% 156
2024
Q1
$336K Buy
4,584
+95
+2% +$7.3K 0.04% 161
2023
Q4
$364K Buy
4,489
+100
+2% +$7.78K 0.04% 156
2023
Q3
$329K Buy
4,389
+5
+0.1% +$385 0.04% 157
2023
Q2
$338K Sell
4,384
-56
-1% -$4.47K 0.04% 159
2023
Q1
$368K Sell
4,440
-92
-2% -$7.62K 0.05% 149
2022
Q4
$389K Sell
4,532
-1,160
-20% -$91.9K 0.05% 143
2022
Q3
$351K Sell
5,692
-300
-5% -$18.9K 0.05% 147
2022
Q2
$370K Sell
5,992
-100
-2% -$6.19K 0.06% 136
2022
Q1
$362K Sell
6,092
-400
-6% -$25.6K 0.05% 145
2021
Q4
$471K Sell
6,492
-26
-0.4% -$1.79K 0.06% 134
2021
Q3
$455K Hold
6,518
0.06% 132
2021
Q2
$449K Sell
6,518
-500
-7% -$33.4K 0.06% 130
2021
Q1
$454K Sell
7,018
-1
-0% -$64 0.07% 122
2020
Q4
$409K Sell
7,019
-199
-3% -$12K 0.07% 123
2020
Q3
$456K Hold
7,218
0.09% 98
2020
Q2
$555K Sell
7,218
-30
-0.4% -$2.3K 0.12% 92
2020
Q1
$542K Buy
7,248
+600
+9% +$41.5K 0.13% 86
2019
Q4
$432K Buy
6,648
+126
+2% +$8.21K 0.08% 105
2019
Q3
$413K Buy
6,522
+365
+6% +$23.9K 0.08% 102
2019
Q2
$416K Buy
6,157
+200
+3% +$13.2K 0.08% 104
2019
Q1
$387K Hold
5,957
0.08% 104
2018
Q4
$373K Sell
5,957
-42,648
-88% -$2.98M 0.08% 100
2018
Q3
$3.75M Buy
48,605
+41,398
+574% +$3.13M 1.68% 24
2018
Q2
$511K Sell
7,207
-600
-8% -$42.4K 0.11% 86
2018
Q1
$589K Hold
7,807
0.13% 78
2017
Q4
$559K Sell
7,807
-525
-6% -$39.9K 0.12% 78
2017
Q3
$675K Hold
8,332
0.15% 64
2017
Q2
$590K Sell
8,332
-500
-6% -$33.3K 0.13% 67
2017
Q1
$600K Buy
8,832
+190
+2% +$13.4K 0.14% 66
2016
Q4
$619K Buy
8,642
+4,087
+90% +$304K 0.15% 64
2016
Q3
$360K Sell
4,555
-2,645
-37% -$215K 0.05% 132
2016
Q2
$601K Buy
7,200
+725
+11% +$64.3K 0.17% 56
2016
Q1
$595K Sell
6,475
-100
-2% -$9.02K 0.21% 55
2015
Q4
$665K Sell
6,575
-350
-5% -$36.4K 0.25% 45
2015
Q3
$680K Sell
6,925
-375
-5% -$41.6K 0.29% 39
2015
Q2
$855K Sell
7,300
-450
-6% -$49.2K 0.32% 35
2015
Q1
$761K Buy
7,750
+400
+5% +$40.6K 0.29% 40
2014
Q4
$693K Buy
7,350
+2,610
+55% +$270K 0.28% 43
2014
Q3
$505K Sell
4,740
-25
-0.5% -$2.45K 0.23% 51
2014
Q2
$395K Buy
4,765
+2,275
+91% +$177K 0.19% 60
2014
Q1
$176K Buy
2,490
+450
+22% +$35.3K 0.09% 95
2013
Q4
$153K Sell
2,040
-230
-10% -$16K 0.08% 95
2013
Q3
$143K Sell
2,270
-114
-5% -$6.81K 0.09% 94
2013
Q2
$122K Buy
+2,384
New +$124K 0.08% 102

Other funds holding GILD

JNBA Financial Advisors's GILD Position: Q2 2026 in Review

JNBA Financial Advisors increased its Gilead Sciences (GILD) stake by 0.71% in Q2 2026, buying an estimated $3.95K and bringing the position to 4,283 shares worth $541K. The position accounts for 0.04% of the portfolio, ranked #138.

JNBA Financial Advisors first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.75M in Q3 2018. 758 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • JNBA Financial Advisors held 4,283 shares of Gilead Sciences worth $541K as of Q2 2026.
  • JNBA Financial Advisors bought 30 Gilead Sciences shares in Q2 2026, an estimated $3.95K.
  • Gilead Sciences made up 0.04% of JNBA Financial Advisors's portfolio in Q2 2026, its #138 holding.
  • JNBA Financial Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • JNBA Financial Advisors's Gilead Sciences position peaked at $3.75M in Q3 2018.
  • 758 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on JNBA Financial Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.